Lauren E. Cipriano

3.8k total citations · 1 hit paper
73 papers, 2.4k citations indexed

About

Lauren E. Cipriano is a scholar working on Epidemiology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lauren E. Cipriano has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 19 papers in Economics and Econometrics and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lauren E. Cipriano's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Dementia and Cognitive Impairment Research (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Lauren E. Cipriano is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Dementia and Cognitive Impairment Research (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Lauren E. Cipriano collaborates with scholars based in Canada, United States and Iran. Lauren E. Cipriano's co-authors include Luciano A. Sposato, Vladimir Hachinski, Gustavo Saposnik, Patricia M. Riccio, Estefanía Ruíz Vargas, Gregory S. Zaric, Douglas K Owens, Jeremy D. Goldhaber‐Fiebert, Mark Holodniy and G. Scott Gazelle and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Lauren E. Cipriano

70 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis

2015 437 citations Luciano A. Sposato, Lauren E. Cipriano et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren E. Cipriano Canada	28	804	694	562	298	247	73	2.4k
Armin Koch Germany	32	644 0.8×	507 0.7×	464 0.8×	361 1.2×	83 0.3×	125	3.1k
Brittany Lapin United States	30	529 0.7×	344 0.5×	437 0.8×	985 3.3×	109 0.4×	184	3.1k
Lars Johansson Sweden	24	533 0.7×	402 0.6×	330 0.6×	399 1.3×	230 0.9×	52	2.8k
Marieke D. Spreeuwenberg Netherlands	29	416 0.5×	1.1k 1.6×	1.1k 1.9×	306 1.0×	282 1.1×	70	3.3k
Jason T. Connor United States	33	812 1.0×	343 0.5×	478 0.9×	1.3k 4.4×	93 0.4×	69	3.6k
Jin‐Hyung Jung South Korea	31	502 0.6×	1.1k 1.6×	266 0.5×	305 1.0×	182 0.7×	174	2.9k
Valeria Raparelli Italy	32	748 0.9×	1.2k 1.8×	121 0.2×	385 1.3×	136 0.6×	136	3.1k
Laura Antolini Italy	26	290 0.4×	355 0.5×	412 0.7×	272 0.9×	241 1.0×	120	2.3k
Justina Wu United States	19	550 0.7×	1.0k 1.5×	154 0.3×	445 1.5×	135 0.5×	45	2.3k
Douglas G. Altman United Kingdom	21	294 0.4×	414 0.6×	335 0.6×	441 1.5×	172 0.7×	30	2.5k

Countries citing papers authored by Lauren E. Cipriano

Since Specialization

Citations

This map shows the geographic impact of Lauren E. Cipriano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren E. Cipriano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren E. Cipriano more than expected).

Fields of papers citing papers by Lauren E. Cipriano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren E. Cipriano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren E. Cipriano. The network helps show where Lauren E. Cipriano may publish in the future.

Co-authorship network of co-authors of Lauren E. Cipriano

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren E. Cipriano. A scholar is included among the top collaborators of Lauren E. Cipriano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren E. Cipriano. Lauren E. Cipriano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kolla, Gillian, et al.. (2025). Opioid medication doses among safer supply clients: Current safer supply doses and previous OAT experience. Drug and Alcohol Dependence Reports. 15. 100338–100338. 2 indexed citations

Cipriano, Lauren E., Cassandra McDonald, Mayur Brahmania, et al.. (2024). Propofol sedation does not improve measures of colonoscopy quality but increase cost – findings from a large population-based cohort study. EClinicalMedicine. 70. 102503–102503. 2 indexed citations

Colijn, Caroline, Naveed Z. Janjua, Tyler Williamson, et al.. (2024). Canada’s provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses. Canadian Journal of Public Health. 115(4). 541–557. 1 indexed citations

Sorrentino, Pierpaolo, Emahnuel Troisi Lopez, Lauren E. Cipriano, et al.. (2024). The virtual multiple sclerosis patient. iScience. 27(7). 110101–110101. 6 indexed citations

Tran, Christopher, Lauren E. Cipriano, & David K. Driman. (2023). Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021. CMAJ Open. 11(3). E475–E484. 5 indexed citations

Goldhaber‐Fiebert, Jeremy D. & Lauren E. Cipriano. (2023). Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis. Medical Decision Making. 43(7-8). 914–929.

Cipriano, Lauren E., et al.. (2023). Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada. PharmacoEconomics. 42(1). 69–90. 1 indexed citations

Palaniyappan, Lena, et al.. (2023). Risk stratification for treating people at ultra-high risk for psychosis: A cost-effectiveness analysis. Schizophrenia Research. 261. 225–233. 1 indexed citations

Vilches, Thomas N., Elaheh Abdollahi, Lauren E. Cipriano, et al.. (2022). Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study. BMC Public Health. 22(1). 1042–1042. 8 indexed citations

10.

Cerasuolo, Joshua O., Mahmoud Reza Azarpazhooh, Moira K. Kapral, Lauren E. Cipriano, & Vladimir Hachinski. (2018). Evidence of Concomitantly Increasing Stroke and Dementia Prevalence among those 80 Years and Older in Ontario, Canada, 2003-04 to 2012-13. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46(1). 105–107. 4 indexed citations

11.

Racosta, Juan Manuel, et al.. (2015). Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis. Multiple Sclerosis and Related Disorders. 4(2). 104–111. 36 indexed citations

12.

Sposato, Luciano A., Lauren E. Cipriano, Gustavo Saposnik, et al.. (2015). Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. The Lancet Neurology. 14(4). 377–387. 437 indexed citations breakdown →

13.

Liu, Shan, Lauren E. Cipriano, Mark Holodniy, & Jeremy D. Goldhaber‐Fiebert. (2013). Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States. PLoS ONE. 8(3). e58975–e58975. 58 indexed citations

14.

Liu, Shan, Lauren E. Cipriano, Mark Holodniy, Douglas K Owens, & Jeremy D. Goldhaber‐Fiebert. (2012). New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Author Names. Annals of Internal Medicine. 156(4). 279. 1 indexed citations

15.

Park, K.T., et al.. (2012). Cost-Effectiveness of Early Colectomy With Ileal Pouch-Anal Anastamosis Versus Standard Medical Therapy in Severe Ulcerative Colitis. Annals of Surgery. 256(1). 117–124. 32 indexed citations

16.

Cipriano, Lauren E., Gregory S. Zaric, Mark Holodniy, et al.. (2012). Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users. PLoS ONE. 7(9). e45176–e45176. 46 indexed citations

17.

McMahon, Pamela M., Chung Yin Kong, Colleen Bouzan, et al.. (2011). Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States. Journal of Thoracic Oncology. 6(11). 1841–1848. 170 indexed citations

18.

Cipriano, Lauren E., Barrett G. Levesque, Gregory S. Zaric, Edward V. Loftus, & William J. Sandborn. (2011). Cost-Effectiveness of Imaging Strategies to Reduce Radiation-Induced Cancer Risk in Crohnʼs Disease. Inflammatory Bowel Diseases. 18(7). 1240–1248. 43 indexed citations

19.

Levesque, Barrett G., Lauren E. Cipriano, Steven L. Chang, et al.. (2009). Cost Effectiveness of Alternative Imaging Strategies for the Diagnosis of Small-Bowel Crohn's Disease. Clinical Gastroenterology and Hepatology. 8(3). 261–267.e4. 40 indexed citations

20.

McMahon, Pamela M., Chung Yin Kong, Milton C. Weinstein, et al.. (2008). Adopting helical CT screening for lung cancer. Cancer. 113(12). 3440–3449. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact